From today's email.
We recently have revised the Medicare Supplement 2050/2070 product underwriting guidelines to include the following changes:
Additional reasons for decline:
Injections administered in the doctor's office.
Lung or respiratory disorders: use of nebulizer within the past 12 months.
Lung or respiratory disorder with tobacco use.
History of cardiovascular event (such as a heart attack, stroke or TIA) in combination with tobacco use.
If the applicant has diabetes, falls within the height/weight range for the standard rate and uses tobacco.
The applicant is prescribed Furosemide/Lasix over 60 mg daily.
The applicant is prescribed a combination of Methotrexate and a steroid (such as Prednisone).
The applicant has diabetes and takes or has been required to take more than 50 units of insulin daily in the past two years.
We recently have revised the Medicare Supplement 2050/2070 product underwriting guidelines to include the following changes:
Additional reasons for decline:
Injections administered in the doctor's office.
Lung or respiratory disorders: use of nebulizer within the past 12 months.
Lung or respiratory disorder with tobacco use.
History of cardiovascular event (such as a heart attack, stroke or TIA) in combination with tobacco use.
If the applicant has diabetes, falls within the height/weight range for the standard rate and uses tobacco.
The applicant is prescribed Furosemide/Lasix over 60 mg daily.
The applicant is prescribed a combination of Methotrexate and a steroid (such as Prednisone).
The applicant has diabetes and takes or has been required to take more than 50 units of insulin daily in the past two years.